{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:07:10Z","timestamp":1793761630786,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jconrel.2019.11.009","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T02:30:42Z","timestamp":1573525842000},"page":"273-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":300,"special_numbering":"C","title":["Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes"],"prefix":"10.1016","volume":"317","author":[{"given":"Gyeungyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Woo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Won","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-9296","authenticated-orcid":false,"given":"Minhyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.11.009_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-011-0793-0","article-title":"Recent advances in the molecular understanding of glioblastoma","volume":"108","author":"Bleeker","year":"2012","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0010","doi-asserted-by":"crossref","first-page":"E273","DOI":"10.3747\/co.22.2436","article-title":"Nonsurgical treatment of recurrent glioblastoma","volume":"22","author":"Gallego","year":"2015","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/neuonc\/not137","article-title":"Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma","volume":"16","author":"Chaichana","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/nos273","article-title":"Standards of care for treatment of recurrent glioblastoma-are we there yet?","volume":"15","author":"Weller","year":"2013","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2009.06.034","article-title":"MicroRNA involvement in glioblastoma pathogenesis","volume":"386","author":"Novakova","year":"2009","journal-title":"Biochem Bioiphys Res Com"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0040","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0045","first-page":"C1541","article-title":"Programmed cell death protein 4 suppresses CDK1\/cdc2 via induction of p21(Waf1\/Cip1)","volume":"287","author":"Goke","year":"2004","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterol"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1039\/C7BM01088E","article-title":"A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model","volume":"6","author":"Tan","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/1061186X.2016.1207648","article-title":"Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model","volume":"25","author":"Oh","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0070","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain Cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0075","doi-asserted-by":"crossref","first-page":"U179","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2015.10.002","article-title":"A novel platform for cancer therapy using extracellular vesicles","volume":"95","author":"Tominaga","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","article-title":"Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia","volume":"7","author":"Yang","year":"2017","journal-title":"Mol. Ther-Nucl. Acids"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0090","article-title":"Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0095","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1021\/acs.molpharmaceut.5b00222","article-title":"Enhancing Glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin\/transferrin receptor complex","volume":"12","author":"Kang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R","article-title":"Targeted drug delivery to C6 glioma by transferrin-coupled liposomes","volume":"51","author":"Eavarone","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0105","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3171\/jns.1990.72.6.0941","article-title":"Transferrin receptor in Normal and neoplastic brain-tissue - implications for brain-tumor immunotherapy","volume":"72","author":"Recht","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0115","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1432-1327.2001.02073.x","article-title":"Receptor mediated uptake of peptides that bind the human transferrin receptor","volume":"268","author":"Lee","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0120","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1021\/mp100185f","article-title":"Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed Tumors","volume":"7","author":"Han","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nbt.1830","article-title":"SiRNA delivery with exosome nanoparticles","volume":"29","author":"van den Boorn","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0135","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.biomaterials.2011.03.047","article-title":"A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA","volume":"32","author":"Hwang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.08.011","article-title":"RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain","volume":"155","author":"Son","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0145","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.11.009_bb0150","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","article-title":"Specificity, duplex degradation and subcellular localization of antagomirs","volume":"35","author":"Krutzfeldt","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2019.11.009_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA","volume":"13","author":"Krichevsky","year":"2009","journal-title":"J. Cell. Mol. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919306492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919306492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:47:51Z","timestamp":1759160871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919306492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":31,"alternative-id":["S0168365919306492"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}